Cook Biotech specializes in the development of advanced biomaterials for tissue repair, primarily utilizing naturally occurring extracellular matrices (ECMs) such as porcine small intestinal submucosa (SIS). Their innovative products are designed to facilitate site-specific tissue remodeling, which is crucial for effective healing. The SIS material supports the body's natural healing processes by allowing cells and capillaries to infiltrate the matrix, delivering nutrients and secreting collagen. This integration results in the formation of organized tissue that provides long-term strength without leaving permanent foreign materials in the body.

The company's product portfolio includes a variety of tissue grafts and repair solutions tailored for different medical applications, including hernia repair, wound management, and soft-tissue reinforcement. Cook Biotech's Biodesign® line features multiple graft options, such as 1-layer and 4-layer tissue grafts, as well as specialized products for head and neck, chest, abdomen, pelvis, and extremities. With over 25 years of experience, Cook Biotech has successfully produced millions of advanced tissue-repair products, demonstrating their commitment to improving patient outcomes through innovative medical solutions.

United States

Cook Biotech Incorporated, an RTI Surgical company, is a world leader in regenerative medicine, was established in 1995 to develop and manufacture biologic tissue grafts utilizing extracellular matrix (ECM) technology. Cook Biotech products have been used in soft-tissue-repair treatments worldwide, including treatment for fistulas, hernias, and wounds.

Cook Biotech

Company Details